PRIME DIABETES HEART NUTRITION
Aae32-1001	The Health Benefits of Almonds
	Quote:	Almonds have long been recognized as one of the healthiest nuts in the world. Native to the Middle East but now cultivated extensively in California, Spain, and Australia, almonds are rich in healthy fats, plant protein, fiber, vitamins, minerals, and powerful phytochemicals. Numerous clinical trials and epidemiological studies have demonstrated that regular almond consumption supports cardiovascular health, blood sugar control, weight management, cognitive function, gut health, and healthy aging.
	Article:	https://richardgoldberg.substack.com/p/the-health-benefits-of-almonds
	Search Similar:	Brave Mojeek Startpage Dogpile Bing Googl Lycos Utub Yaho
PRIME DIABETES IMMUNE
Bpa32-003	Single Cell Mapping Identifies CD14 Macrophages as Central Orchestrators of CD8 T Cell Driven Immune Niches in clinical Type 1 diabetes
	Quote:	Together, these findings identify CD14#8314; macrophages as key orchestrators of a feed-forward inflammatory circuit driving human islet autoimmunity.
	Article:	https://www.biorxiv.org/content/10.64898/2026.08.06.743319v1
	Search Similar:	Brave Mojeek Startpage Dogpile Bing Googl Lycos Utub Yaho
	Search Authors:	Madhu Chakkere Shivamadhu Xiangyu Zhang Vijay K Yechoor Kacey Prentice Babak Razani Michael B Wheeler Md Saifur Rahman Khan,
DIABETES HEART
Mdb32-014	A Deep Learning-Derived Insulin Resistance Index for Cardiovascular Risk Prediction: A Prospective Cohort Study with External Validation in Chinese and US Populations
	Quote:	The MoE-derived DNN-IR index demonstrated robust and stable performance in predicting atherosclerosis, incident CVD, cardiovascular mortality, and all-cause mortality in the general population. Further validation in larger, more diverse cohorts is warranted to support its broad clinical applicability.
	Abstract:	https://www.medrxiv.org/content/10.64898/2026.08.10.26360145v1
	Full Text:	https://www.medrxiv.org/content/10.64898/2026.08.10.26360145v1.full-text
	Search Similar:	Brave Mojeek Startpage Dogpile Bing Googl Lycos Utub Yaho
	Search Authors:	Yaqian Mao Jing Lin Ao Zhou Shuhang Zeng Dan Yang Wei Lin Junping Wen Wenjie Yang Gang Chen,
PRIME CANCER DIABETES DIAGNOSTICS
Mga32-018	Assessment of impending pancreatic cancer in a cohort of new onset diabetes on basis of biomarker trajectory
	Quote:	CONCLUSION In the setting of adult new onset diabetes, CA19-9 is a readily available and promising biomarker that can be leveraged for earlier detection of an underlying pancreatic cancer. Additional protein biomarkers may improve sensitivity for earlier detection of PDAC among cases with low CA19-9.
	Abstract:	https://www.medrxiv.org/content/10.64898/2026.08.06.26359908v1
	Full Text:	https://www.medrxiv.org/content/10.64898/2026.08.06.26359908v1.full-text
	Search Similar:	Brave Mojeek Startpage Dogpile Bing Googl Lycos Utub Yaho
	Search Authors:	Ehsan Irajizad Camden Lopez Suresh Chari Jody Vykoukal Rachelle Spencer Yaxi Li Jennifer B. Dennison Eugene J. Koay Florencia McAllister Michael Kim Matthew Young Phil A. Hart Willam Fisher Stephen K. Vandeneeden Bechien U. Wu Ziding Feng Samir Hanash Anirban Maitra Johannes F. Fahrmann,
DIABETES KIDNEYS
Mkd32-003	The Urine Ammonium-pH Index is a Measure of Kidney Tubular Function
	Quote:	In type 2 diabetes patients with preserved GFR, a reduced uAPI was associated with faster kidney function decline. In three CKD cohorts, low uAPI predicted CKD progression and significantly improved risk prediction. Together, this positions the uAPI as a scalable, non-invasive measure of kidney tubular function.
	Abstract:	https://www.medrxiv.org/content/10.64898/2026.08.06.26359870v1
	Full Text:	https://www.medrxiv.org/content/10.64898/2026.08.06.26359870v1.full-text
	Search Similar:	Brave Mojeek Startpage Dogpile Bing Googl Lycos Utub Yaho
	Search Authors:	Jesper Frank Andersen Mads Vaarby Srensen Maria Chrysopoulou Sren Gullaksen Steffen Flindt Nielsen Sandra Hummelgaard Niklas Ayasse Iben Skov Jensen Louise Salomo Natasja P. Simonsen Jasmine CL Atay Per Lgstrup Poulsen Rikke Nrregaard Liv Vernstrm Kathrin Weyer Fatih Demir Samuel Levi Svendsen Alan M. Weinstein Sebastian Nielsen Marie Bodilsen Nielsen Niels Henrik Buus Henrik Birn I. David Weiner Markus Rinschen Jens Leipziger Peder Berg,
BRAIN BRAINWAVE DIABETES
Mpa32-003	Targeted Pulsed Radio Frequency (PRF) Stimulation in the Management of Diabetic Peripheral Neuropathy: A Randomized, Single-Blind, Placebo-Controlled Trial
	Quote:	Conclusion: A brief, three-week course of non-invasive PRF stimulation serves as a safe, effective, non-pharmacological adjunct that aids in managing the diagnostic presentation of neuropathic pain and mitigates worst pain experiences in patients suffering from pedal DPN.
	Abstract:	https://www.medrxiv.org/content/10.64898/2026.08.07.26359945v1
	Full Text:	https://www.medrxiv.org/content/10.64898/2026.08.07.26359945v1.full-text
	Search Similar:	Brave Mojeek Startpage Dogpile Bing Googl Lycos Utub Yaho
	Search Authors:	Lukas D Linde Phyllis P Berger Stanley S Landau Elena Libhaber Paul Potgieter Petra van Blerk Corlius F Birkill,

Javilk's Research Links Newsletter for Week 32
Updated 08/15/2026-01:24:35 AM
What interests you? What have you found? Tell me!
Drop me a note to subscribe or submit something.

Aae32-1001

The Health Benefits of Almonds

Bpa32-003

Single Cell Mapping Identifies CD14 Macrophages as Central Orchestrators of CD8 T Cell Driven Immune Niches in clinical Type 1 diabetes

Mdb32-014

A Deep Learning-Derived Insulin Resistance Index for Cardiovascular Risk Prediction: A Prospective Cohort Study with External Validation in Chinese and US Populations

Mga32-018

Assessment of impending pancreatic cancer in a cohort of new onset diabetes on basis of biomarker trajectory

Mkd32-003

The Urine Ammonium-pH Index is a Measure of Kidney Tubular Function

Mpa32-003

Targeted Pulsed Radio Frequency (PRF) Stimulation in the Management of Diabetic Peripheral Neuropathy: A Randomized, Single-Blind, Placebo-Controlled Trial